Monogram Orthopaedics Inc. Common Stock (MGRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has a cash flow conversion efficiency ratio of -0.267x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.30 Million) by net assets ($8.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MGRM defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Monogram Orthopaedics Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Monogram Orthopaedics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Okins Electronics Co. Ltd
KQ:080580
|
0.113x |
|
Curexo Inc
KQ:060280
|
-0.016x |
|
Shin Shin Natural Gas Co Ltd
TW:9918
|
0.038x |
|
W&T Offshore Inc
NYSE:WTI
|
-0.154x |
|
Dimand S.A.
AT:DIMAND
|
N/A |
|
Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée
PA:CRAV
|
-0.105x |
|
Santhera Pharmaceuticals Holding AG
SW:SANN
|
1.199x |
|
Dong-A St
KO:170900
|
0.003x |
Annual Cash Flow Conversion Efficiency for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual cash flow conversion efficiency of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Monogram Orthopaedics Inc. Common Stock worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.50 Million | $-13.97 Million | -0.963x | +4.72% |
| 2023-12-31 | $13.40 Million | $-13.54 Million | -1.011x | +50.18% |
| 2022-12-31 | $4.15 Million | $-8.42 Million | -2.029x | +22.46% |
| 2021-12-31 | $3.50 Million | $-9.17 Million | -2.617x | -141.63% |
| 2020-12-31 | $4.99 Million | $-5.40 Million | -1.083x | -128.37% |
| 2019-12-31 | $-274.63K | $-1.05 Million | 3.817x | +1630.44% |
| 2018-12-31 | $-1.39 Million | $-306.87K | 0.221x | -75.86% |
| 2017-12-31 | $-677.81K | $-619.37K | 0.914x | -- |
About Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more